Ann: Sweden initiates inquiry to overturn uranium mining ban, page-226

First 226 Last

Share
Profile

Follow
asxbets42069

107 Posts.

10

04/09/24

10:35

Post #: 75520765
Share
Originally posted by dc1234: ↑

Writing here after a while.

Reason being I picked up some AEE recently. I have already had one trade. Had bought at 12.5 and sold at 14, a portion of my holding, but bought back at 12.5 again.

An important week coming for the stock. And maybe for the sector - all U stocks.
.
Will we bottom from here or keep falling into an abyss? We don't know. I use CCJ as an example, and I have written my theory. I am also playing according to - nearly exactly what I have been saying for last several months, including last top and bottom. I did get the top write (end May/start June), but no confirmation of bottom yet.
.
AEE needs to hold this level. Its already down around 60% from its high of 35.5, slightly higher than other U stocks though. Bottom number to watch, 11.5, up number to watch 16. Anything in between, usual noise/consolidation play.
.
Personally I am playing here, have bought in last few weeks, my average 12
.
This is what I have written about U sector in my Weekly Report this week. Anyone more interested, look at my other posts.
.
Uranium Sector overview- I have been writing for couple of months, May end top, July end bottom, September end top. CCJ to reverse from here. I was writing that 39/40 is critical level, and a move in either direction may provide medium term direction. Last week it was looking positive and finished at 42.61. This week there was a scare and tested the first lower level of 39/40. It came to 40.22, but this level has held for now. It finished the week at 40.84, towards the high of the day, having a green Friday. So as I wrote last week, a churn around the critical level may happen. I have also been writing till it crosses 45 and stays above that, reversal will not be confirmed. So we still don't have a confirmation. But odds that 35 may have been the bottom for this phase is still good. My play of bottoming here and topping Sep end/Oct begin is still intact. I have bought around 90% of what I had wanted to buy, 40% 3 weeks back, another 40% 2 week back, another 5% last week, another 5% this week, but I also did a good amount of trading and brought some of my averages. I do love to trade and play with 30%, many times on daily basis. Spot price is also in a scare/drama, dipped below psychological number of 80, at 79.25 down from 82.40 of last week. It needs to hold here for a reversal to U stocks. So my theory is still in play, but anything can happen, so please dyor.

.

Expand

dangerously close to your bottom number...
AEE Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 43 more messages in this thread...

First 226 Last

Add AEE (ASX) to my watchlist

(20min delay)
Last 15.5¢		Change 0.000(0.00%)		Mkt cap ! $128.1M

Open	High	Low	Value	Volume
16.0¢	16.0¢	15.5¢	$108.3K	684.0K

Buyers (Bids)

No.	Vol.	Price($)
5	249509	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	226000	3

View Market Depth

No.	Vol.	Price($)
5	249509	0.155
12	1188866	0.150
6	656888	0.145
9	760237	0.140
2	290010	0.135

Price($)	Vol.	No.
0.160	226000	3
0.165	145000	2
0.170	293537	7
0.175	262300	4
0.180	572750	9

Last trade - 16.10pm 07/10/2024 (20 minute delay)

AEE (ASX) Chart

Ann: Sweden initiates inquiry to overturn uranium mining ban, page-226

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Sweden initiates inquiry to overturn uranium mining ban, page-226

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News